BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T080000
DTEND;TZID=America/New_York:20191115T170000
DTSTAMP:20260716T055012
CREATED:20191021T132047Z
LAST-MODIFIED:20191021T132047Z
UID:6876-1572768000-1573837200@scienceinboston.com
SUMMARY:Leadership Development for Physicians in Academic Health Centers
DESCRIPTION:Overview\n\nAcademic health centers in the United States are experiencing major change as a result of the effects of health reform and financial pressures. In addition to the restructuring of the clinical enterprise\, academic centers are being challenged to sustain their academic missions and priorities in the face of resource constraints. In order to tackle these challenges\, institutions need physicians in administrative positions at all levels who can provide leadership and thoughtful managerial initiatives. \nFor over forty years Harvard has conducted intensive two-week executive development programs designed specifically for chairs\, chiefs\, and medical directors in clinical departments at major teaching hospitals. During that time\, leaders from institutions in all regions of the United States have participated in and praised these unique educational programs. \nLeadership Development for Physicians in Academic Health Centers is designed to serve a wide array of physician leaders. It convenes medical directors and chiefs of divisions from academic health centers together with an interdisciplinary faculty team for two weeks of intensive and systematic study of the critical leadership and management issues faced by physicians in administrative positions and academic health centers. \nCurriculum \nThe curriculum is organized around the following interrelated courses taught by a faculty experienced in executive education for physicians and other key decision-makers in the health system: \n\nInstitutional Strategy\nFinancial Analysis\nOperations Management\nOrganizational Issues\nConflict Resolution and Negotiation\nLeadership\nHealth Policy\n\nA carefully integrated curriculum permits participants to examine fundamental leadership and managerial issues from the perspective of several disciplines. The overriding purpose for learning concepts\, techniques and skills in any of the management disciplines in this program is to understand their managerial use and limitations. \nTeaching Methods \nThe principal method of instruction in the program is the case method\, a technique pioneered and refined at the Harvard Business School. Most of the cases present actual problem situations familiar to physicians in administrative positions at academic health centers. \nThe case method confronts the participant with an actual management problem\, halted at a point where decisions must be made\, and empowers the participant to choose a course of action. \nParticipants go through a three-step study process. First\, participants study each case independently. Then they meet in small discussion groups to test their individual analysis against those of their peers. Lastly\, the entire class discusses the case\, with the professor as a catalyst and guide. The professor points out considerations the class has overlooked; elicits from participants the lessons of experience; pursues each line of investigation to its conclusion; and finally\, summarizes the discussion and draws out the major lessons it has taught. \nAssigned readings and guest lecturers supplement and augment the use of cases. In addition\, an important part of the learning process occurs during the informal exchange of insights and experience among participants and between participants and faculty. \nCourse Website
URL:https://scienceinboston.com/event/leadership-development-for-physicians-in-academic-health-centers/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191103T080000
DTEND;TZID=America/New_York:20191115T170000
DTSTAMP:20260716T055012
CREATED:20191021T132047Z
LAST-MODIFIED:20191021T132047Z
UID:27348-1572768000-1573837200@scienceinboston.com
SUMMARY:Leadership Development for Physicians in Academic Health Centers
DESCRIPTION:Overview\n\nAcademic health centers in the United States are experiencing major change as a result of the effects of health reform and financial pressures. In addition to the restructuring of the clinical enterprise\, academic centers are being challenged to sustain their academic missions and priorities in the face of resource constraints. In order to tackle these challenges\, institutions need physicians in administrative positions at all levels who can provide leadership and thoughtful managerial initiatives. \nFor over forty years Harvard has conducted intensive two-week executive development programs designed specifically for chairs\, chiefs\, and medical directors in clinical departments at major teaching hospitals. During that time\, leaders from institutions in all regions of the United States have participated in and praised these unique educational programs. \nLeadership Development for Physicians in Academic Health Centers is designed to serve a wide array of physician leaders. It convenes medical directors and chiefs of divisions from academic health centers together with an interdisciplinary faculty team for two weeks of intensive and systematic study of the critical leadership and management issues faced by physicians in administrative positions and academic health centers. \nCurriculum \nThe curriculum is organized around the following interrelated courses taught by a faculty experienced in executive education for physicians and other key decision-makers in the health system: \n\nInstitutional Strategy\nFinancial Analysis\nOperations Management\nOrganizational Issues\nConflict Resolution and Negotiation\nLeadership\nHealth Policy\n\nA carefully integrated curriculum permits participants to examine fundamental leadership and managerial issues from the perspective of several disciplines. The overriding purpose for learning concepts\, techniques and skills in any of the management disciplines in this program is to understand their managerial use and limitations. \nTeaching Methods \nThe principal method of instruction in the program is the case method\, a technique pioneered and refined at the Harvard Business School. Most of the cases present actual problem situations familiar to physicians in administrative positions at academic health centers. \nThe case method confronts the participant with an actual management problem\, halted at a point where decisions must be made\, and empowers the participant to choose a course of action. \nParticipants go through a three-step study process. First\, participants study each case independently. Then they meet in small discussion groups to test their individual analysis against those of their peers. Lastly\, the entire class discusses the case\, with the professor as a catalyst and guide. The professor points out considerations the class has overlooked; elicits from participants the lessons of experience; pursues each line of investigation to its conclusion; and finally\, summarizes the discussion and draws out the major lessons it has taught. \nAssigned readings and guest lecturers supplement and augment the use of cases. In addition\, an important part of the learning process occurs during the informal exchange of insights and experience among participants and between participants and faculty. \nCourse Website
URL:https://scienceinboston.com/event/leadership-development-for-physicians-in-academic-health-centers-2/
LOCATION:Harvard T.H. Chan School of Public Health\, FXB Building 651 Huntington Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T073000
DTEND;TZID=America/New_York:20191112T103000
DTSTAMP:20260716T055012
CREATED:20191108T230223Z
LAST-MODIFIED:20191108T232338Z
UID:7104-1573543800-1573554600@scienceinboston.com
SUMMARY:Medical Devices\, Market Trends & Opportunities - Educational Breakfast
DESCRIPTION:Please join Greenberg Traurig and Exponent for Medical Devices\, Market Trends & Opportunities – Educational Breakfast on Tuesday\, November 12th\, from 7:30 AM to 10:30 AM at the law firm of Greenberg Traurig located at One International Place\, Suite 2000\, in Boston\, Massachusetts. \nThis educational breakfast will address the trends in the MedTech industry\, identify the opportunities for innovators to develop IP\, examine the energy and power management for medical devices\, and develop understanding on requirements and constraints that originate from patients\, physicians\, and regulatory agencies. \n\n\nAGENDA\n7:30 – 8:00 AM Breakfast and Networking \n8:00 – 9:30 AM Panel Discussion \n\nGeoff DaCosta\nDavid Dykman\nDr. David Borsook\, M.D\nDr. Alexander Margulis\, Ph.D.\n\n9:45 – 10:30 AM Presentations: \n\nQuinn C. Horn\, Ph.D.\, P.E. – Battery Selection for Medical Devices\nSergio Mendoza\, Ph.D. – System Requirements for Battery Powered Medical Devices\n\n\n\nSPEAKERS\nQuinn C. Horn\, Ph.D.\, P.E.\, Principal\, Exponent \nDr. Horn has over 20 years of experience solving complex battery safety problems.  Prior to joining Exponent in 2004\, Dr. Horn led the failure analysis group at Energizer/Eveready Battery Company\, where he conducted failure analysis studies on a wide variety of commercial battery systems including lithium-ion\, lithium-primary\, nickel-metal hydride\, nickel cadmium\, lead-acid\, and alkaline primary cells. He is a Research Affiliate at the Massachusetts Institute of Technology\, where he collaborates with researchers in the Electrochemical Energy Laboratory. \n\n\nDavid Dykeman\, Shareholder\, Greenberg Traurig \nDavid Dykeman\, who co-chairs the firm’s global Life Sciences & Medical Technology Group\, is a registered patent attorney with more than 20 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients\, with particular experience in life sciences\, medical devices\, robotics\, materials\, and information technology. David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions\, multi-national corporations\, and start-up companies. \n\n\nGeoff DaCosta\, Director of Business Development & Licensing\, Medtronic \nGeoff DaCosta is currently a Director of Business Development and Licensing within the Surgical Innovations business of Medtronic\, where he coordinates strategic partnership and M&A activities. Geoff joined Medtronic in 2015 following its acquisition of Covidien PLC.  He started with Covidien in 2008\, serving in various roles\, including Director of Strategy and Business Development within the Vascular Therapies business. Previously\, he worked in the Transaction Advisory Services group of Ernst & Young\, as well as multiple Boston boutique advisory firms. Geoff holds an MBA from the UCLA Anderson School of Management and a BA in Economics from the University of Pennsylvania. \n\n\nAlex Margulis\, Ph.D.\, Chief Operating Officer\, Mansfield Bio-Incubator \nDr. Margulis is currently leveraging his scientific and business acumen to manage the operations and business development at Mansfield Bio-Incubator. Concurrently\, he is working as a Business Development Manager (New England) in a boutique life science and marketing strategy organization. Previously\, while working at Precision Biosystems where he developed and executed a strategy to increase the sales by 100% within 1 year while managing a team of manufacturer’s representatives. Beforehand\, he worked as a Senior Scientist at BIOARRAY Therapeutics\, where he managed the project to set up a fully functional laboratory 33% ahead of schedule while saving money and developed proof-of-concept assays for the company’s leading diagnostic test. \n\n\nDavid Borsook\, MD\, PhD\, Professor\, Harvard Medical School \nDr. Borsook is a Professor at Harvard Medical School.  He has a background in Neurology (MD) and Neurobiology (PhD) and an interest in transferring new technologies into the biotech space. Aside from research focus\, he had a long clinical involvement in pain medicine at MGH\, including being the Director of Pain Medicine at the institution.  He has published nearly 300 articles in peer reviewed journals. His Research Program – The Center for Pain and the Brain – at  Boston Children’s\, Massachusetts General and McLean Hospitals evaluates brain and nerve markers of pain and analgesics. He has authored a number of patents\, was the Chief Scientific Officer of a Biotech he founded and has licensed IP to industry. \n\n\nSergio Mendoza\, Ph.D.\, Senior Associate\, Exponent \nDr. Mendoza is a system engineer who builds on his controls background to perform multi-level analysis on electrified systems pertaining to different industries including automotive\, medical and consumer electronics. His areas of expertise include optimal design of experiments to minimize the cost of experimentation while maximizing the statistical meaning of the data collected; model-based energy\, power and thermal control of battery powered systems\, and estimation of the lifetime of lithium-ion cells. Furthermore\, Dr. Mendoza applies his extensive knowledge of lithium-ion cells and systems background to conduct Design Failure Mode and Effects Analysis (DFMEA) and safety analyses including Preliminary Hazard Analyses (PHA).
URL:https://scienceinboston.com/event/medical-devices-market-trends-opportunities-educational-breakfast/
LOCATION:Greenberg Traurig\, LLP\, One International Place\, #Suite 2000\, Boston\, MA\, 02110\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T073000
DTEND;TZID=America/New_York:20191112T103000
DTSTAMP:20260716T055012
CREATED:20191108T230223Z
LAST-MODIFIED:20191108T230223Z
UID:27368-1573543800-1573554600@scienceinboston.com
SUMMARY:Medical Devices\, Market Trends & Opportunities - Educational Breakfast
DESCRIPTION:Please join Greenberg Traurig and Exponent for Medical Devices\, Market Trends & Opportunities – Educational Breakfast on Tuesday\, November 12th\, from 7:30 AM to 10:30 AM at the law firm of Greenberg Traurig located at One International Place\, Suite 2000\, in Boston\, Massachusetts. \nThis educational breakfast will address the trends in the MedTech industry\, identify the opportunities for innovators to develop IP\, examine the energy and power management for medical devices\, and develop understanding on requirements and constraints that originate from patients\, physicians\, and regulatory agencies. \n\n\nAGENDA\n7:30 – 8:00 AM Breakfast and Networking \n8:00 – 9:30 AM Panel Discussion \n\nGeoff DaCosta\nDavid Dykman\nDr. David Borsook\, M.D\nDr. Alexander Margulis\, Ph.D.\n\n9:45 – 10:30 AM Presentations: \n\nQuinn C. Horn\, Ph.D.\, P.E. – Battery Selection for Medical Devices\nSergio Mendoza\, Ph.D. – System Requirements for Battery Powered Medical Devices\n\n\n\nSPEAKERS\nQuinn C. Horn\, Ph.D.\, P.E.\, Principal\, Exponent \nDr. Horn has over 20 years of experience solving complex battery safety problems.  Prior to joining Exponent in 2004\, Dr. Horn led the failure analysis group at Energizer/Eveready Battery Company\, where he conducted failure analysis studies on a wide variety of commercial battery systems including lithium-ion\, lithium-primary\, nickel-metal hydride\, nickel cadmium\, lead-acid\, and alkaline primary cells. He is a Research Affiliate at the Massachusetts Institute of Technology\, where he collaborates with researchers in the Electrochemical Energy Laboratory. \n\n\nDavid Dykeman\, Shareholder\, Greenberg Traurig \nDavid Dykeman\, who co-chairs the firm’s global Life Sciences & Medical Technology Group\, is a registered patent attorney with more than 20 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients\, with particular experience in life sciences\, medical devices\, robotics\, materials\, and information technology. David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions\, multi-national corporations\, and start-up companies. \n\n\nGeoff DaCosta\, Director of Business Development & Licensing\, Medtronic \nGeoff DaCosta is currently a Director of Business Development and Licensing within the Surgical Innovations business of Medtronic\, where he coordinates strategic partnership and M&A activities. Geoff joined Medtronic in 2015 following its acquisition of Covidien PLC.  He started with Covidien in 2008\, serving in various roles\, including Director of Strategy and Business Development within the Vascular Therapies business. Previously\, he worked in the Transaction Advisory Services group of Ernst & Young\, as well as multiple Boston boutique advisory firms. Geoff holds an MBA from the UCLA Anderson School of Management and a BA in Economics from the University of Pennsylvania. \n\n\nAlex Margulis\, Ph.D.\, Chief Operating Officer\, Mansfield Bio-Incubator \nDr. Margulis is currently leveraging his scientific and business acumen to manage the operations and business development at Mansfield Bio-Incubator. Concurrently\, he is working as a Business Development Manager (New England) in a boutique life science and marketing strategy organization. Previously\, while working at Precision Biosystems where he developed and executed a strategy to increase the sales by 100% within 1 year while managing a team of manufacturer’s representatives. Beforehand\, he worked as a Senior Scientist at BIOARRAY Therapeutics\, where he managed the project to set up a fully functional laboratory 33% ahead of schedule while saving money and developed proof-of-concept assays for the company’s leading diagnostic test. \n\n\nDavid Borsook\, MD\, PhD\, Professor\, Harvard Medical School \nDr. Borsook is a Professor at Harvard Medical School.  He has a background in Neurology (MD) and Neurobiology (PhD) and an interest in transferring new technologies into the biotech space. Aside from research focus\, he had a long clinical involvement in pain medicine at MGH\, including being the Director of Pain Medicine at the institution.  He has published nearly 300 articles in peer reviewed journals. His Research Program – The Center for Pain and the Brain – at  Boston Children’s\, Massachusetts General and McLean Hospitals evaluates brain and nerve markers of pain and analgesics. He has authored a number of patents\, was the Chief Scientific Officer of a Biotech he founded and has licensed IP to industry. \n\n\nSergio Mendoza\, Ph.D.\, Senior Associate\, Exponent \nDr. Mendoza is a system engineer who builds on his controls background to perform multi-level analysis on electrified systems pertaining to different industries including automotive\, medical and consumer electronics. His areas of expertise include optimal design of experiments to minimize the cost of experimentation while maximizing the statistical meaning of the data collected; model-based energy\, power and thermal control of battery powered systems\, and estimation of the lifetime of lithium-ion cells. Furthermore\, Dr. Mendoza applies his extensive knowledge of lithium-ion cells and systems background to conduct Design Failure Mode and Effects Analysis (DFMEA) and safety analyses including Preliminary Hazard Analyses (PHA).
URL:https://scienceinboston.com/event/medical-devices-market-trends-opportunities-educational-breakfast-2/
LOCATION:Greenberg Traurig\, LLP\, One International Place\, #Suite 2000\, Boston\, MA\, 02110\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T080000
DTEND;TZID=America/New_York:20191112T170000
DTSTAMP:20260716T055012
CREATED:20191108T231301Z
LAST-MODIFIED:20191108T232235Z
UID:7108-1573545600-1573578000@scienceinboston.com
SUMMARY:New Biotech Funding Models: Is The Tech Revolution Coming?
DESCRIPTION:Early-stage financing and company creation models have evolved significantly over the last two decades from heavily-funded\, brick & mortar\, do or die entities to angel-enabled\, virtual and minimalistic proof of concept start-ups with hand-selected management and externally-enabled resources and ecosystems. Indeed\, the Funding Model for emerging biotech companies appears to borrow from the tech company funding models from two decades prior\, including incubators and accelerators\, angel investors\, shared laboratory and clinical facilities\, “venture engineering” and shared resource programs. At this MassBio program\, under the auspices of Entrepreneurs University\, we will explore the current funding models in vogue today\, the investor landscape\, the impact of advancing science and technology\, new types of partnerships\, and the novel approaches early-stage companies are executing to advance to the next stage of existence – and funding round. Finally\, our panel will provide their ideas on the future of venture funding and early-stage funding models in the biotech industry\, and open the program to a lively discussion with the audience. Our moderator for this program is the inimitable\, ever-effervescent John Hession. Please join us. \nSponsored by the MassBio Entrepreneurs University Working group.
URL:https://scienceinboston.com/event/new-biotech-funding-models-is-the-tech-revolution-coming/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T080000
DTEND;TZID=America/New_York:20191112T170000
DTSTAMP:20260716T055012
CREATED:20191108T231301Z
LAST-MODIFIED:20191108T231301Z
UID:27369-1573545600-1573578000@scienceinboston.com
SUMMARY:New Biotech Funding Models: Is The Tech Revolution Coming?
DESCRIPTION:Early-stage financing and company creation models have evolved significantly over the last two decades from heavily-funded\, brick & mortar\, do or die entities to angel-enabled\, virtual and minimalistic proof of concept start-ups with hand-selected management and externally-enabled resources and ecosystems. Indeed\, the Funding Model for emerging biotech companies appears to borrow from the tech company funding models from two decades prior\, including incubators and accelerators\, angel investors\, shared laboratory and clinical facilities\, “venture engineering” and shared resource programs. At this MassBio program\, under the auspices of Entrepreneurs University\, we will explore the current funding models in vogue today\, the investor landscape\, the impact of advancing science and technology\, new types of partnerships\, and the novel approaches early-stage companies are executing to advance to the next stage of existence – and funding round. Finally\, our panel will provide their ideas on the future of venture funding and early-stage funding models in the biotech industry\, and open the program to a lively discussion with the audience. Our moderator for this program is the inimitable\, ever-effervescent John Hession. Please join us. \nSponsored by the MassBio Entrepreneurs University Working group.
URL:https://scienceinboston.com/event/new-biotech-funding-models-is-the-tech-revolution-coming-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T110000
DTEND;TZID=America/New_York:20191112T130000
DTSTAMP:20260716T055012
CREATED:20191108T231459Z
LAST-MODIFIED:20191108T232021Z
UID:7110-1573556400-1573563600@scienceinboston.com
SUMMARY:Lunch & Learn: Staying In Compliance With Pipette Calibrations
DESCRIPTION:Eppendorf\, the preferred pipette calibration provider for MassBio Edge will be conducting a lunch & learn seminar on the importance of proper pipette calibration procedures and standards. Eppendorf is a world leader in manufacturing and calibrating liquid handling devices. Their extensive knowledge on pipette calibrations will help ensure your company is in compliance\, while avoiding downtime\, recalls and penalties. \nSpeakers:\nMarcela Sanclemente – Director\, Calibration Service\nBob Fortin – Director\, Global Key Accounts\nJim Ford – Area Vice President\, Northeast \nFor more information contact Craig Carew.
URL:https://scienceinboston.com/event/lunch-learn-staying-in-compliance-with-pipette-calibrations/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T110000
DTEND;TZID=America/New_York:20191112T130000
DTSTAMP:20260716T055012
CREATED:20191108T231459Z
LAST-MODIFIED:20191108T231459Z
UID:27370-1573556400-1573563600@scienceinboston.com
SUMMARY:Lunch & Learn: Staying In Compliance With Pipette Calibrations
DESCRIPTION:Eppendorf\, the preferred pipette calibration provider for MassBio Edge will be conducting a lunch & learn seminar on the importance of proper pipette calibration procedures and standards. Eppendorf is a world leader in manufacturing and calibrating liquid handling devices. Their extensive knowledge on pipette calibrations will help ensure your company is in compliance\, while avoiding downtime\, recalls and penalties. \nSpeakers:\nMarcela Sanclemente – Director\, Calibration Service\nBob Fortin – Director\, Global Key Accounts\nJim Ford – Area Vice President\, Northeast \nFor more information contact Craig Carew.
URL:https://scienceinboston.com/event/lunch-learn-staying-in-compliance-with-pipette-calibrations-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T110000
DTEND;TZID=America/New_York:20191112T130000
DTSTAMP:20260716T055012
CREATED:20191108T231936Z
LAST-MODIFIED:20191108T231936Z
UID:7112-1573556400-1573563600@scienceinboston.com
SUMMARY:Rapid approach to new scaffold generation
DESCRIPTION:Overview\n\nScaffold hopping remains a central task in medicinal chemistry for generating and protecting intellectual property. This hands-on workshop will focus on quickly generating novel ideas and bioisosteres for molecule cores using Spark. The standard functionality of Spark™ as well as advanced search options will be presented. Topics include the choice of databases to search\, how to link searches and results to available databases\, using excluded volumes\, field point and pharmacophore constraints to incorporate relevant protein information in the search. \nHands-on: If you wish to follow along in this hands-on workshop then please bring a laptop (a download link to Spark will be provided before the event if needed). \nWho should attend: Medicinal\, synthetic and computational chemists. Some familiarity with Spark an advantage.
URL:https://scienceinboston.com/event/rapid-approach-to-new-scaffold-generation/
LOCATION:CIC\, Charles Room\, 14th Floor\, CIC\, 1 Broadway\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191112T110000
DTEND;TZID=America/New_York:20191112T130000
DTSTAMP:20260716T055012
CREATED:20191108T231936Z
LAST-MODIFIED:20191108T231936Z
UID:27371-1573556400-1573563600@scienceinboston.com
SUMMARY:Rapid approach to new scaffold generation
DESCRIPTION:Overview\n\nScaffold hopping remains a central task in medicinal chemistry for generating and protecting intellectual property. This hands-on workshop will focus on quickly generating novel ideas and bioisosteres for molecule cores using Spark. The standard functionality of Spark™ as well as advanced search options will be presented. Topics include the choice of databases to search\, how to link searches and results to available databases\, using excluded volumes\, field point and pharmacophore constraints to incorporate relevant protein information in the search. \nHands-on: If you wish to follow along in this hands-on workshop then please bring a laptop (a download link to Spark will be provided before the event if needed). \nWho should attend: Medicinal\, synthetic and computational chemists. Some familiarity with Spark an advantage.
URL:https://scienceinboston.com/event/rapid-approach-to-new-scaffold-generation-2/
LOCATION:CIC\, Charles Room\, 14th Floor\, CIC\, 1 Broadway\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191113T080000
DTEND;TZID=America/New_York:20191114T170000
DTSTAMP:20260716T055012
CREATED:20191112T121150Z
LAST-MODIFIED:20191112T121150Z
UID:7133-1573632000-1573750800@scienceinboston.com
SUMMARY:Biomanufacturing for the Non-Specialist: What You Need to Know
DESCRIPTION:This two day course is designed to introduce the participants to the exciting field of biomanufacturing with special emphasis on how biologics are manufactured for commercial use. Presentations by professionals from industry and academia will be delivered within the BETC biomanufacturing facility which is set up as a pilot scale industrial biomanufacturing suite to allow participants to see and feel the equipment and processes discussed. \n\nProgram Start: November 13-14\, 2019\nRegistration Deadline: Two weeks prior to program start\nTime: 8:00am – 4:00pm\nLocation: Biomanufacturing Education & Training Center (BETC) WPI Gateway Park 2\, 50 Prescott Street (2nd floor)\, Worcester MA\nCost: $1\,950\nCEU: 1.4\nThere are no academic prerequisites for this program \n\nWho Should Attend \nAnyone who needs a concise understanding of biologics production and the manufacturing processes to advance their career\, including but not limited to: sales & marketing staff at industry vendors/suppliers\, recruiters\, environmental health and safety specialists\, operations personnel\, supply chain personnel\, students\, manufacturing personnel\, maintenance personnel (mfg. support)\, financial officers\, project managers and career changers.
URL:https://scienceinboston.com/event/biomanufacturing-for-the-non-specialist-what-you-need-to-know/
LOCATION:Biomanufacturing Education & Training Center (BETC) WPI Gateway Park 2\, 50 Prescott Street (2nd floor)\, Worcester\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191113T080000
DTEND;TZID=America/New_York:20191114T170000
DTSTAMP:20260716T055012
CREATED:20191112T121150Z
LAST-MODIFIED:20191112T121150Z
UID:27372-1573632000-1573750800@scienceinboston.com
SUMMARY:Biomanufacturing for the Non-Specialist: What You Need to Know
DESCRIPTION:This two day course is designed to introduce the participants to the exciting field of biomanufacturing with special emphasis on how biologics are manufactured for commercial use. Presentations by professionals from industry and academia will be delivered within the BETC biomanufacturing facility which is set up as a pilot scale industrial biomanufacturing suite to allow participants to see and feel the equipment and processes discussed. \n\nProgram Start: November 13-14\, 2019\nRegistration Deadline: Two weeks prior to program start\nTime: 8:00am – 4:00pm\nLocation: Biomanufacturing Education & Training Center (BETC) WPI Gateway Park 2\, 50 Prescott Street (2nd floor)\, Worcester MA\nCost: $1\,950\nCEU: 1.4\nThere are no academic prerequisites for this program \n\nWho Should Attend \nAnyone who needs a concise understanding of biologics production and the manufacturing processes to advance their career\, including but not limited to: sales & marketing staff at industry vendors/suppliers\, recruiters\, environmental health and safety specialists\, operations personnel\, supply chain personnel\, students\, manufacturing personnel\, maintenance personnel (mfg. support)\, financial officers\, project managers and career changers.
URL:https://scienceinboston.com/event/biomanufacturing-for-the-non-specialist-what-you-need-to-know-2/
LOCATION:Biomanufacturing Education & Training Center (BETC) WPI Gateway Park 2\, 50 Prescott Street (2nd floor)\, Worcester\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191113T120000
DTEND;TZID=America/New_York:20191113T130000
DTSTAMP:20260716T055012
CREATED:20191112T121553Z
LAST-MODIFIED:20191112T121553Z
UID:7136-1573646400-1573650000@scienceinboston.com
SUMMARY:M2D2 presents: Lunch and Learn with ClinicalBid
DESCRIPTION:You’re ready to start your trial. Fantastic! Who do you partner with? How do you find the right CRO? Do you know if they submitted a competitive price? What about staffing the trial? How will you recruit patients? What if your trial needs rescuing? \nDon’t worry – ClinicalBid has you covered. Please join us for lunch on Wednesday\, November 13\, 2019 from 12:00pm-1:00pm at UMass Medical School\, Worcester\, MA in the Albert Sherman Center AS7.2072 to learn how ClinicalBid’s Private RFP Platform will help you coordinate vendors and streamline the quoting process.  We are here to help you. Lunch will be provided. To learn more about us\, visit our website: https://clinicalbid.com
URL:https://scienceinboston.com/event/m2d2-presents-lunch-and-learn-with-clinicalbid/
LOCATION:UMass Medical School\, Sherman Center\, 7th Floor\, room AS7.2072 55 North Lake Ave\, Worcester\, MA\, 01655\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191113T120000
DTEND;TZID=America/New_York:20191113T130000
DTSTAMP:20260716T055012
CREATED:20191112T121553Z
LAST-MODIFIED:20191112T121553Z
UID:27373-1573646400-1573650000@scienceinboston.com
SUMMARY:M2D2 presents: Lunch and Learn with ClinicalBid
DESCRIPTION:You’re ready to start your trial. Fantastic! Who do you partner with? How do you find the right CRO? Do you know if they submitted a competitive price? What about staffing the trial? How will you recruit patients? What if your trial needs rescuing? \nDon’t worry – ClinicalBid has you covered. Please join us for lunch on Wednesday\, November 13\, 2019 from 12:00pm-1:00pm at UMass Medical School\, Worcester\, MA in the Albert Sherman Center AS7.2072 to learn how ClinicalBid’s Private RFP Platform will help you coordinate vendors and streamline the quoting process.  We are here to help you. Lunch will be provided. To learn more about us\, visit our website: https://clinicalbid.com
URL:https://scienceinboston.com/event/m2d2-presents-lunch-and-learn-with-clinicalbid-2/
LOCATION:UMass Medical School\, Sherman Center\, 7th Floor\, room AS7.2072 55 North Lake Ave\, Worcester\, MA\, 01655\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191114T163000
DTEND;TZID=America/New_York:20191114T210000
DTSTAMP:20260716T055012
CREATED:20191112T122043Z
LAST-MODIFIED:20191112T122043Z
UID:7139-1573749000-1573765200@scienceinboston.com
SUMMARY:Biosciences Seminar with Nobel Prize Winner Sir Prof Richard Roberts\, Chief Scientific Officer at New England Biolabs
DESCRIPTION:Overview\n\nNSTC: Year of Genomics Signature Event \nThe North Shore region is home to a thriving life science (particularly genomics) community including one of our co-host for this event: New England Biolabs. \nThis event will celebrate: \n\n\nKeynote: “Genomics and common sense to improve practical applications of biotechnology”\nThe scientific credibility of the region\nThe north of Boston as a great place to work\n\nThe event will include: \n\nKeynote\nSpeakers from leading genomics companies\nTable top exhibits\nHiring event breakout for companies to speak directly to students and early career candidates\nNetworking\n\nKeynote Speaker: Nobel prize winner\, Dr. Richard J. Roberts\, Chief Scientific Officer\, New England Biolabs\, Beverly\, Massachusetts. \nDr. Richard J. Roberts received a Ph.D. in Organic Chemistry in 1968 from Sheffield University and then moved as a postdoctoral fellow to Harvard. From 1972 to 1992\, he worked at Cold Spring Harbor Laboratory\, eventually becoming Assistant Director for Research under Dr. J.D. Watson. He began work on the newly discovered Type II restriction enzymes in 1972 and these enzymes have been a major research theme. \nStudies of transcription in Adenovirus-2 led to the discovery of split genes and mRNA splicing in 1977\, for which he received the Nobel Prize in Medicine in 1993. During the sequencing of the Adenovirus-2 genome computational tools became essential and his laboratory pioneered the application of computers in this area. DNA methyltransferases\, as components of restriction-modification systems are also of active interest and the first crystal structures for the HhaI methyltransferase led to the discovery of base flipping. Bioinformatic studies of microbial genomes to find new restriction systems are a major research focus as is the elucidation of DNA methyltransferase recognition sequences using SMRT sequencing and a new approach to m5C containing recognition sequences. \nDriving directions to Rose Performance Hall: Rose Performance Hall is located in the Walter J. Manninen Center for the Arts: \nTake Route 95 North to Route 128 North (Exit 45). Take Exit 17 (Grapevine Road\, Beverly Farms). Turn right off the exit ramp and right again after 1.5 miles onto Haskell Street (by the cemetery). Proceed to the end\, and at the stop sign\, turn right onto Hale Street/Route 127. Travel approximately 1.5 miles on Route 127 to Endicott College. \nThe first (receiving) entrance to the College is on the right. If the gate is open\, turn right into the campus and proceed straight up the roadway. The Manninen Center is on the left at the top of the hill. Limited parking is available in Lot 15 adjacent to the center. For additional parking\, continue past the center and turn left after Gloucester Hall into Lots 13 and 14. \nThe second (main) entrance is also on the right (approximately 300 yards beyond the first entrance). Enter the campus\, drive past the Public Safety building on the left\, and continue straight ahead to the main campus road (Endicott Drive)\, which loops around the campus. Pass the Chapel and Callahan Center on the left and the Gerrish School of Business/ Judge Science Center on the right. Continue past Hempstead Stadium and the Post Center on the left\, and proceed down the steep hill. On the right are Lots 13 and 14 -large parking areas that are accessed through an entry point at Gloucester Hall are on the right. \nTo view the campus map\, go to https://map.endicott.edu/ \n  \nCost/Registration Info\n\n$0.00 Executive Members\n$5.00 Individual and InTransition Members\n$5.00 Students\n$10.00 Partners\nVeterans – no charge; email nstcstaff@gmail.com for discount code\n$30.00 All Others\nAt-the-Door registration: $20 for members; $35 for all others.
URL:https://scienceinboston.com/event/biosciences-seminar-with-nobel-prize-winner-sir-prof-richard-roberts-chief-scientific-officer-at-new-england-biolabs/
LOCATION:Endicott College – Rose Performance Hall\, Walter J. Manninen Center for the Arts 376 Hale Street\, Beverly\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191114T163000
DTEND;TZID=America/New_York:20191114T210000
DTSTAMP:20260716T055012
CREATED:20191112T122043Z
LAST-MODIFIED:20191112T122043Z
UID:27374-1573749000-1573765200@scienceinboston.com
SUMMARY:Biosciences Seminar with Nobel Prize Winner Sir Prof Richard Roberts\, Chief Scientific Officer at New England Biolabs
DESCRIPTION:Overview\n\nNSTC: Year of Genomics Signature Event \nThe North Shore region is home to a thriving life science (particularly genomics) community including one of our co-host for this event: New England Biolabs. \nThis event will celebrate: \n\n\nKeynote: “Genomics and common sense to improve practical applications of biotechnology”\nThe scientific credibility of the region\nThe north of Boston as a great place to work\n\nThe event will include: \n\nKeynote\nSpeakers from leading genomics companies\nTable top exhibits\nHiring event breakout for companies to speak directly to students and early career candidates\nNetworking\n\nKeynote Speaker: Nobel prize winner\, Dr. Richard J. Roberts\, Chief Scientific Officer\, New England Biolabs\, Beverly\, Massachusetts. \nDr. Richard J. Roberts received a Ph.D. in Organic Chemistry in 1968 from Sheffield University and then moved as a postdoctoral fellow to Harvard. From 1972 to 1992\, he worked at Cold Spring Harbor Laboratory\, eventually becoming Assistant Director for Research under Dr. J.D. Watson. He began work on the newly discovered Type II restriction enzymes in 1972 and these enzymes have been a major research theme. \nStudies of transcription in Adenovirus-2 led to the discovery of split genes and mRNA splicing in 1977\, for which he received the Nobel Prize in Medicine in 1993. During the sequencing of the Adenovirus-2 genome computational tools became essential and his laboratory pioneered the application of computers in this area. DNA methyltransferases\, as components of restriction-modification systems are also of active interest and the first crystal structures for the HhaI methyltransferase led to the discovery of base flipping. Bioinformatic studies of microbial genomes to find new restriction systems are a major research focus as is the elucidation of DNA methyltransferase recognition sequences using SMRT sequencing and a new approach to m5C containing recognition sequences. \nDriving directions to Rose Performance Hall: Rose Performance Hall is located in the Walter J. Manninen Center for the Arts: \nTake Route 95 North to Route 128 North (Exit 45). Take Exit 17 (Grapevine Road\, Beverly Farms). Turn right off the exit ramp and right again after 1.5 miles onto Haskell Street (by the cemetery). Proceed to the end\, and at the stop sign\, turn right onto Hale Street/Route 127. Travel approximately 1.5 miles on Route 127 to Endicott College. \nThe first (receiving) entrance to the College is on the right. If the gate is open\, turn right into the campus and proceed straight up the roadway. The Manninen Center is on the left at the top of the hill. Limited parking is available in Lot 15 adjacent to the center. For additional parking\, continue past the center and turn left after Gloucester Hall into Lots 13 and 14. \nThe second (main) entrance is also on the right (approximately 300 yards beyond the first entrance). Enter the campus\, drive past the Public Safety building on the left\, and continue straight ahead to the main campus road (Endicott Drive)\, which loops around the campus. Pass the Chapel and Callahan Center on the left and the Gerrish School of Business/ Judge Science Center on the right. Continue past Hempstead Stadium and the Post Center on the left\, and proceed down the steep hill. On the right are Lots 13 and 14 -large parking areas that are accessed through an entry point at Gloucester Hall are on the right. \nTo view the campus map\, go to https://map.endicott.edu/ \n  \nCost/Registration Info\n\n$0.00 Executive Members\n$5.00 Individual and InTransition Members\n$5.00 Students\n$10.00 Partners\nVeterans – no charge; email nstcstaff@gmail.com for discount code\n$30.00 All Others\nAt-the-Door registration: $20 for members; $35 for all others.
URL:https://scienceinboston.com/event/biosciences-seminar-with-nobel-prize-winner-sir-prof-richard-roberts-chief-scientific-officer-at-new-england-biolabs-2/
LOCATION:Endicott College – Rose Performance Hall\, Walter J. Manninen Center for the Arts 376 Hale Street\, Beverly\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191114T180000
DTEND;TZID=America/Vancouver:20191114T190000
DTSTAMP:20260716T055012
CREATED:20191112T122403Z
LAST-MODIFIED:20191112T173030Z
UID:7143-1573754400-1573758000@scienceinboston.com
SUMMARY:Broad@15 - From Genes to Mechanisms to Medicines: Reflections on the past\, present\, and future of drug discovery
DESCRIPTION:Overview\n\nFrom Genes to Mechanisms to Medicines: Reflections on the past\, present\, and future of drug discovery\nAnna Greka & Florence Wagner\n6:00-7:00pm\nAuditorium | 415 Main Street\nCambridge\, MA \nSince the Human Genome Project\, our understanding of the genetic basis of human diseases has grown by leaps and bounds. But how close are we to translating these genetic insights into much-needed therapies? Physician-scientist Anna Greka and chemist Florence Wagner will reflect on how new tools and approaches in biology and chemistry have helped unlock new paradigms for the development of medicines in the genomic era\, and look ahead to what the future might hold. \nTo register or live stream the talk\, visit broadinstitute.org/15.
URL:https://scienceinboston.com/event/broad15-from-genes-to-mechanisms-to-medicines-reflections-on-the-past-present-and-future-of-drug-discovery/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20191114T180000
DTEND;TZID=America/Vancouver:20191114T190000
DTSTAMP:20260716T055012
CREATED:20191112T122403Z
LAST-MODIFIED:20191112T122403Z
UID:27375-1573754400-1573758000@scienceinboston.com
SUMMARY:Broad@15 - From Genes to Mechanisms to Medicines: Reflections on the past\, present\, and future of drug discovery
DESCRIPTION:Overview\n\nFrom Genes to Mechanisms to Medicines: Reflections on the past\, present\, and future of drug discovery\nAnna Greka & Florence Wagner\n6:00-7:00pm\nAuditorium | 415 Main Street\nCambridge\, MA \nSince the Human Genome Project\, our understanding of the genetic basis of human diseases has grown by leaps and bounds. But how close are we to translating these genetic insights into much-needed therapies? Physician-scientist Anna Greka and chemist Florence Wagner will reflect on how new tools and approaches in biology and chemistry have helped unlock new paradigms for the development of medicines in the genomic era\, and look ahead to what the future might hold. \nTo register or live stream the talk\, visit broadinstitute.org/15.
URL:https://scienceinboston.com/event/broad15-from-genes-to-mechanisms-to-medicines-reflections-on-the-past-present-and-future-of-drug-discovery-2/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191114T180000
DTEND;TZID=America/New_York:20191114T190000
DTSTAMP:20260716T055012
CREATED:20191112T122800Z
LAST-MODIFIED:20191112T122800Z
UID:7147-1573754400-1573758000@scienceinboston.com
SUMMARY:Explore a Part-Time M.S. Degree in Biology: Functional Genomics at the Graduate School of Arts and Sciences Studies at Tufts University
DESCRIPTION:Overview\n\nPlease join us for an information session facilitated by Sarah Herchel\, Ph.D.\, the Associate Dean of the Graduate School of Arts and Sciences. Come to the Tufts Medford campus and learn about our part-time opportunities for graduate studies in Arts and Sciences\, and ask questions regarding the admissions process. \nRegister now \nLearn more about the part-time M.S. Biology: Functional Genomics program\, including a sample part-time schedule\, on our website. Questions? Please email pathwaysgsas@tufts.edu.
URL:https://scienceinboston.com/event/explore-a-part-time-m-s-degree-in-biology-functional-genomics-at-the-graduate-school-of-arts-and-sciences-studies-at-tufts-university/
LOCATION:Tufts Medford Campus\, 419 Boston Ave.\, Floor 7\, Medford\, MA\, 02155\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191114T180000
DTEND;TZID=America/New_York:20191114T190000
DTSTAMP:20260716T055012
CREATED:20191112T122800Z
LAST-MODIFIED:20191112T122800Z
UID:27376-1573754400-1573758000@scienceinboston.com
SUMMARY:Explore a Part-Time M.S. Degree in Biology: Functional Genomics at the Graduate School of Arts and Sciences Studies at Tufts University
DESCRIPTION:Overview\n\nPlease join us for an information session facilitated by Sarah Herchel\, Ph.D.\, the Associate Dean of the Graduate School of Arts and Sciences. Come to the Tufts Medford campus and learn about our part-time opportunities for graduate studies in Arts and Sciences\, and ask questions regarding the admissions process. \nRegister now \nLearn more about the part-time M.S. Biology: Functional Genomics program\, including a sample part-time schedule\, on our website. Questions? Please email pathwaysgsas@tufts.edu.
URL:https://scienceinboston.com/event/explore-a-part-time-m-s-degree-in-biology-functional-genomics-at-the-graduate-school-of-arts-and-sciences-studies-at-tufts-university-2/
LOCATION:Tufts Medford Campus\, 419 Boston Ave.\, Floor 7\, Medford\, MA\, 02155\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191115T084500
DTEND;TZID=America/New_York:20191115T173000
DTSTAMP:20260716T055012
CREATED:20191112T123035Z
LAST-MODIFIED:20191112T123035Z
UID:7151-1573807500-1573839000@scienceinboston.com
SUMMARY:Neurodevelopmental Disorder Symposium: A Collaborative Path Forward in Neurodevelopmental Disorders
DESCRIPTION:Overview\n\nOn Friday\, November 15\, 2019 the Translational Neuroscience Center (TNC) at Boston Children’s Hospital\, in collaboration with Massachusetts General Hospital and Massachusetts Institute of Technology\, will host the fifth and final Boston-wide Neurodevelopmental Disorders Symposium in the Joseph B. Martin Conference Center at Harvard Medical School. This symposium will highlight the groundbreaking work that has come out of Boston  autism collaborations and set the stage for the future of autism research in our community. \nThis conference\, sponsored by the Anne and Paul Marcus Family foundation\, is open to scientists and physicians from academia\, the pharmaceutical and biotechnology industries\, disease-based foundations\, and the government and will include distinguished speakers\, a breakout discussion on the future of autism research and poster reception. \nThis year’s all-day event will feature successful collaborations that arose from the Boston Autism Community\, from Drs. Charles Nelson & Mark Bear on Fragile X Syndrome\, Drs. Issac Kohane & Mustafa Sahin on Tuberous Sclerosis Complex\, Drs. Mriganka Sur & Ann Graybiel on Rett Syndrome\, Drs. Rosalind Picard & Terrie Inder on Autism and  Dr. Mark Daly on 16p11 Syndrome. \nOur Keynote Address will be given by Dr. Joseph Buxbaum\, Mount Sinai School of Medicine. \nCapstone Event  In addition to our regular agenda\, this year the symposium will feature a novel breakout session entitled “Laying Seeds for the Future” in which participants will have the opportunity to debate the future of neurodevelopmental research and establish the new collaborations with key opinion leaders in the field.
URL:https://scienceinboston.com/event/neurodevelopmental-disorder-symposium-a-collaborative-path-forward-in-neurodevelopmental-disorders/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191115T084500
DTEND;TZID=America/New_York:20191115T173000
DTSTAMP:20260716T055012
CREATED:20191112T123035Z
LAST-MODIFIED:20191112T123035Z
UID:27377-1573807500-1573839000@scienceinboston.com
SUMMARY:Neurodevelopmental Disorder Symposium: A Collaborative Path Forward in Neurodevelopmental Disorders
DESCRIPTION:Overview\n\nOn Friday\, November 15\, 2019 the Translational Neuroscience Center (TNC) at Boston Children’s Hospital\, in collaboration with Massachusetts General Hospital and Massachusetts Institute of Technology\, will host the fifth and final Boston-wide Neurodevelopmental Disorders Symposium in the Joseph B. Martin Conference Center at Harvard Medical School. This symposium will highlight the groundbreaking work that has come out of Boston  autism collaborations and set the stage for the future of autism research in our community. \nThis conference\, sponsored by the Anne and Paul Marcus Family foundation\, is open to scientists and physicians from academia\, the pharmaceutical and biotechnology industries\, disease-based foundations\, and the government and will include distinguished speakers\, a breakout discussion on the future of autism research and poster reception. \nThis year’s all-day event will feature successful collaborations that arose from the Boston Autism Community\, from Drs. Charles Nelson & Mark Bear on Fragile X Syndrome\, Drs. Issac Kohane & Mustafa Sahin on Tuberous Sclerosis Complex\, Drs. Mriganka Sur & Ann Graybiel on Rett Syndrome\, Drs. Rosalind Picard & Terrie Inder on Autism and  Dr. Mark Daly on 16p11 Syndrome. \nOur Keynote Address will be given by Dr. Joseph Buxbaum\, Mount Sinai School of Medicine. \nCapstone Event  In addition to our regular agenda\, this year the symposium will feature a novel breakout session entitled “Laying Seeds for the Future” in which participants will have the opportunity to debate the future of neurodevelopmental research and establish the new collaborations with key opinion leaders in the field.
URL:https://scienceinboston.com/event/neurodevelopmental-disorder-symposium-a-collaborative-path-forward-in-neurodevelopmental-disorders-2/
LOCATION:Joseph B. Martin Conference Center at the Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191115T133000
DTEND;TZID=America/New_York:20191115T140000
DTSTAMP:20260716T055012
CREATED:20191112T123655Z
LAST-MODIFIED:20191112T123655Z
UID:7154-1573824600-1573826400@scienceinboston.com
SUMMARY:Using Clinical Informatics to Optimize Value-Based Care in the Community
DESCRIPTION:Overview\n\nAs health care spending continues its unsustainable rise\, there is growing pressure to incentivize increased quality and decreased costs. Value-based care models\, which focus on the quality of care instead of the quantity of services\, could address both of these issues. Shifting to a value-based approach\, however\, requires changes across the health care ecosystem—in financing and population health management as well as for payers and providers. \nIn this webinar\, Joe Kimura\, MD will discuss how a high-performing community-based nonprofit health system has systematically applied analytics to drive Population Health management and support value-based care.
URL:https://scienceinboston.com/event/using-clinical-informatics-to-optimize-value-based-care-in-the-community/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191115T133000
DTEND;TZID=America/New_York:20191115T140000
DTSTAMP:20260716T055012
CREATED:20191112T123655Z
LAST-MODIFIED:20191112T123655Z
UID:27378-1573824600-1573826400@scienceinboston.com
SUMMARY:Using Clinical Informatics to Optimize Value-Based Care in the Community
DESCRIPTION:Overview\n\nAs health care spending continues its unsustainable rise\, there is growing pressure to incentivize increased quality and decreased costs. Value-based care models\, which focus on the quality of care instead of the quantity of services\, could address both of these issues. Shifting to a value-based approach\, however\, requires changes across the health care ecosystem—in financing and population health management as well as for payers and providers. \nIn this webinar\, Joe Kimura\, MD will discuss how a high-performing community-based nonprofit health system has systematically applied analytics to drive Population Health management and support value-based care.
URL:https://scienceinboston.com/event/using-clinical-informatics-to-optimize-value-based-care-in-the-community-2/
LOCATION:Harvard Medical School Online Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191116T093000
DTEND;TZID=America/New_York:20191116T140000
DTSTAMP:20260716T055012
CREATED:20191112T124033Z
LAST-MODIFIED:20191112T124033Z
UID:7157-1573896600-1573912800@scienceinboston.com
SUMMARY:Artificial Intelligence Symposium
DESCRIPTION:Overview\n\nGiven the rapid growth and significant impact of Artificial Intelligence and Analytic Platforms in many business sectors\, Framingham State University’s Division of Graduate and Continuing Education is hosting a mini-symposium to discuss on the applications of this new technology within the life sciences industry and to stimulate innovative curriculum development for training in this new frontier. Through a series of speakers and panelists\, this event will allow students and professionals alike to learn and grow this discipline together. \nKeynote Speakers:\n— Patrice M. Milos\, PhD\, Co-Founder/President and CEO\, Medley Genomics Inc.;  Big Data and Robust Data Analytics to Advance Individualization of Cancer Care\n— Maria Wendt\, PhD\, Vice President\, Head of Biologics Research USA\, Sanofi;  Realizing Digitally-Driven Biologics Drug Discovery and Development\n— Steven Moysey\, PhD\, Framingham State University;  Evolution of Work: Automation\, Artificial Intelligence and the New Industrial Age \nPanel Discussion:  Academic Curriculum for the New Frontier\, moderated by Sunny Tam\, PhD \n— Patricia Thomas\, PhD\, Business Department\, FSU \n— Professor David Keil\, Computer Science Department\, FSU \n— Stephen Dinkelacker\, PhD\, Biology Department\, FSU \n— Irene Porro\, PhD\, McAuliffe Center for Integrated Science Learning\, FSU
URL:https://scienceinboston.com/event/artificial-intelligence-symposium/
LOCATION:McCarthy Center\, Forum\, 100 State Street\, Framingham\, MA\, 01701\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191116T093000
DTEND;TZID=America/New_York:20191116T140000
DTSTAMP:20260716T055012
CREATED:20191112T124033Z
LAST-MODIFIED:20191112T124033Z
UID:27379-1573896600-1573912800@scienceinboston.com
SUMMARY:Artificial Intelligence Symposium
DESCRIPTION:Overview\n\nGiven the rapid growth and significant impact of Artificial Intelligence and Analytic Platforms in many business sectors\, Framingham State University’s Division of Graduate and Continuing Education is hosting a mini-symposium to discuss on the applications of this new technology within the life sciences industry and to stimulate innovative curriculum development for training in this new frontier. Through a series of speakers and panelists\, this event will allow students and professionals alike to learn and grow this discipline together. \nKeynote Speakers:\n— Patrice M. Milos\, PhD\, Co-Founder/President and CEO\, Medley Genomics Inc.;  Big Data and Robust Data Analytics to Advance Individualization of Cancer Care\n— Maria Wendt\, PhD\, Vice President\, Head of Biologics Research USA\, Sanofi;  Realizing Digitally-Driven Biologics Drug Discovery and Development\n— Steven Moysey\, PhD\, Framingham State University;  Evolution of Work: Automation\, Artificial Intelligence and the New Industrial Age \nPanel Discussion:  Academic Curriculum for the New Frontier\, moderated by Sunny Tam\, PhD \n— Patricia Thomas\, PhD\, Business Department\, FSU \n— Professor David Keil\, Computer Science Department\, FSU \n— Stephen Dinkelacker\, PhD\, Biology Department\, FSU \n— Irene Porro\, PhD\, McAuliffe Center for Integrated Science Learning\, FSU
URL:https://scienceinboston.com/event/artificial-intelligence-symposium-2/
LOCATION:McCarthy Center\, Forum\, 100 State Street\, Framingham\, MA\, 01701\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191118T080000
DTEND;TZID=America/New_York:20191119T170000
DTSTAMP:20260716T055012
CREATED:20191112T124424Z
LAST-MODIFIED:20191112T124424Z
UID:7160-1574064000-1574182800@scienceinboston.com
SUMMARY:Leading Digital Transformation in Health Care
DESCRIPTION:Overview\n\nWhile technology is beginning to revolutionize health care delivery\, the change process is complex and multifaceted. Which innovations will provide more cost-effective\, patient-centered\, quality care? How do you differentiate value-producing technologies from hype? As a leader\, what are the critical steps in managing the change process? \n“Leading Digital Transformation in Health Care” is a two-day Harvard Medical School executive education program led by John D. Halamka\, MD\, MS\, the International Healthcare Innovation Professor of Emergency Medicine at Harvard Medical School\, and designed to provide you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care.
URL:https://scienceinboston.com/event/leading-digital-transformation-in-health-care/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191118T080000
DTEND;TZID=America/New_York:20191119T170000
DTSTAMP:20260716T055012
CREATED:20191112T124424Z
LAST-MODIFIED:20191112T124424Z
UID:27380-1574064000-1574182800@scienceinboston.com
SUMMARY:Leading Digital Transformation in Health Care
DESCRIPTION:Overview\n\nWhile technology is beginning to revolutionize health care delivery\, the change process is complex and multifaceted. Which innovations will provide more cost-effective\, patient-centered\, quality care? How do you differentiate value-producing technologies from hype? As a leader\, what are the critical steps in managing the change process? \n“Leading Digital Transformation in Health Care” is a two-day Harvard Medical School executive education program led by John D. Halamka\, MD\, MS\, the International Healthcare Innovation Professor of Emergency Medicine at Harvard Medical School\, and designed to provide you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care.
URL:https://scienceinboston.com/event/leading-digital-transformation-in-health-care-2/
LOCATION:Harvard Medical School\, 25 Shattuck St\, Boston\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191118T170000
DTEND;TZID=America/New_York:20191118T210000
DTSTAMP:20260716T055012
CREATED:20191112T124851Z
LAST-MODIFIED:20191112T125135Z
UID:7162-1574096400-1574110800@scienceinboston.com
SUMMARY:Leading Innovation in a Time of Healthcare Change: Dana-Farber Cancer Institute
DESCRIPTION:Overview\n\nDr. Edward J. Benz\, Jr.\, MD\, former president and CEO of Dana-Farber Cancer Institute will talk about Dana-Farber’s role in healthcare innovation and how this large institute interfaces with the advances and boundaries in science\, public policy\,  philanthropy and industry. Dr. Benz will explore the impediments to the effective translation of scientific advances for the public and how organizations can both successfully traverse these boundaries and exploit their synergies. \nMore information: https://bentley.edu/sciindustry \nThis event is part of the Center for Integration of Science and Industry’s Innovator’s Business Series
URL:https://scienceinboston.com/event/leading-innovation-in-a-time-of-healthcare-change-dana-farber-cancer-institute/
LOCATION:Bentley University\, LaCava Center\, 175 Forest Street\, Waltham\, MA\, 02452\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191118T170000
DTEND;TZID=America/New_York:20191118T210000
DTSTAMP:20260716T055012
CREATED:20191112T124851Z
LAST-MODIFIED:20191112T124851Z
UID:27381-1574096400-1574110800@scienceinboston.com
SUMMARY:Leading Innovation in a Time of Healthcare Change: Dana-Farber Cancer Institute
DESCRIPTION:Overview\n\nDr. Edward J. Benz\, Jr.\, MD\, former president and CEO of Dana-Farber Cancer Institute will talk about Dana-Farber’s role in healthcare innovation and how this large institute interfaces with the advances and boundaries in science\, public policy\,  philanthropy and industry. Dr. Benz will explore the impediments to the effective translation of scientific advances for the public and how organizations can both successfully traverse these boundaries and exploit their synergies. \nMore information: https://bentley.edu/sciindustry \nThis event is part of the Center for Integration of Science and Industry’s Innovator’s Business Series
URL:https://scienceinboston.com/event/leading-innovation-in-a-time-of-healthcare-change-dana-farber-cancer-institute-2/
LOCATION:Bentley University\, LaCava Center\, 175 Forest Street\, Waltham\, MA\, 02452\, United States
END:VEVENT
END:VCALENDAR